In drug development, efficacy is a primary endpoint in clinical trials. Before a new drug is approved, it must demonstrate sufficient efficacy in treating the targeted condition. Regulatory agencies, such as the FDA, require extensive evidence of efficacy through preclinical and clinical studies. These studies help ensure that the benefits of a drug outweigh its risks, which is a fundamental criterion for market approval.
